baber/WOPTO huggingface dataset:
Patent NZ-538131-A (NZ)
Title: Anchoring device and its implementation
Inventor: PETROS PETER EMMANUEL
IPC: A61F2/08
Filed: 2003-08-15
Abstract: Disclosed is a method of providing ligamentory like support between two spaced locations in the body of a patient comprising fixing an anchor in each location, connecting the anchors by a filamentary element, adjusting the tension of the filamentary element between the locations to establish the desired spatial relationship between the locations to provide at least a supplementary ligamentory support between the locations. The anchor (115) comprising a base (153), a head (157) having a configuration to facilitate insertion of the head into tissue and retention of the head in the tissue once inserted, the base formed with an aperture (161) adapted to receive a length of a filamentary element (127) and permit slidable movement of the filamentary element through the aperture in one direction but to restrict movement of the filamentary element through the aperture in the opposite direction. A holder (189) to support the anchor to effect is fixation into the tissue and an insertion appliance (173) to support the holder and be used in applying the anchor to the tissue.
Patent NZ-541503-A (NZ)
Title: Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: C07K16/32
Filed: 2004-01-22
Abstract: Disclosed are isolated nucleic acids comprising a sequence encoding a fusion polypeptide, wherein said fusion polypeptide has beta(I,4)-N-acetylglucosaminyltransferase III activity or beta(1,4)-galactosyltransferase activity and comprises the Golgi localization domain of a mammalian Golgi resident polypeptide. Also disclosed are the fusion polypeptides encoded by the said nucleic acids and their use in glycosylation engineering of host cells to generate polypeptides with improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
Patent NZ-543850-A (NZ)
Title: Methods for identifying and using amyloid-inhibitory compounds
Inventor: PETANESCA SUZANA
IPC: A61K31/4535
Filed: 2000-11-03
Abstract: Disclosed is the use of a conjugated equine estrogen compound in the manufacture of a medicament to reduce, delay or prevent the onset of, or ameliorate, a disease or disorder caused directly or indirectly by amyloidosis, by reducing the in vivo level of amyloid-beta peptides in the brain of an animal without affecting soluble APP levels, the medicament including an amount of estrogen selected to fall within about 0.300 mg/day to about 2.5 mg/day.
Patent NZ-543963-A (NZ)
Title: Retroreflective device
Inventor: PARKER ALAN
Filed: 2005-12-02
Abstract: An internally-illuminated retro-reflective device, comprising a light source housed within a cylinder and at least one disc including an optically-transmissive material affixed to a retro-reflective material removably attached to an end of the cylinder is disclosed.
Patent NZ-548443-A (NZ)
Title: Starting system for a single-phase induction motor
Inventor: SCHWARZ MARCOS GUILHERME
IPC: H02P27/02
Filed: 2004-12-09
Abstract: A starting system for a single-phase induction motor is disclosed. The starting system includes a stator having a running coil (11) and a starting coil (12), a power source (F) which supplies current to the running coil (11) and the starting coil (12), a running switch (S1), and a starting switch (S2) connecting the running coil (11) and the starting coil (12) to the power source (F) when in a closed condition. The starting switch (S2) is changed to an open condition upon completion of the motor start, and a control unit (30), is supplied by the power source (F) and operatively connected to both the running switch (S1) and the starting switch (S2) in order to instruct the open and closed conditions. The control unit (30) is programmed to operate the running switch (S1) to cause a delay in the supply of the current supplied to the running coil (11) in relation to the supply of the current supplied to the starting coil (12) during the motor start, for a determined time interval, which is previously defined and considered from the zero-crossing moment of the current supplied to the stator.
Patent NZ-551405-A (NZ)
Title: Pyrazole derivatives, compositions containing such compounds and methods of use
Inventor: PARMEE EMMA R
IPC: A61K31/415
Filed: 2005-05-31
Abstract: Disclosed is a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof, with substituents as described in the specification. Also disclosed is the use of the compound to treat type 2 diabetes mellitus, hyperglycemia, diabetes, insulin resistance, obesity, Syndrome X, atherosclerosism, or a lipid disorder such as dyslipidemiam, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL, or high LDL.
Patent NZ-551513-A (NZ)
Title: Encoder apparatus, encoding method, decoder apparatus, decoding method, program, program recording medium, data recording medium, data structure, and playback apparatus
Inventor: TAKAHASHI KUNIAKI
IPC: H04N19/625
Filed: 2005-06-03
Abstract: An encoding apparatus that encodes a picture is disclosed. The apparatus comprises a encoding means for encoding the picture; picture determining means for determining whether the picture is an interlace-scanned picture or a progressive-scanned picture; flag set means for setting the determined result of the picture determining means to a scanning flag that represents a scanning system of a picture; information set means for setting information that represents a display system of a picture to display system designation information that designates a display system of a picture, and multiplexing means for multiplexing the encoded result of the picture with the scanning flag and the display system designation information and outputting the multiplexed result. The scanning flag is ct_type defined in the H.264/AVC standard and the display system designation information is pic_struct defined in the H.264/AVC standard. A decoding apparatus that decodes encoded data of a picture is also disclosed. The apparatus comprises: decoding means for decoding the encoded data having been multiplexed with an encoded result of the picture, a scanning flag that represents a scanning system of the picture and display system designation information that designates a display system of the picture; recognition means for recognizing the picture as an interlace-scanned picture or a progressive scanned picture on the basis of the scanning flag and the display system designation information of the picture;frame picture output means for interpolating the picture with fields, generating a frame picture, and outputting it when the recognized result of the recognition means is an interlace-scanned picture and for outputting the picture as a frame picture when the recognized result of the recognition means is a progressive-scanned picture; and repetitive output means for repetitively outputting the frame picture that is output from the frame picture output means only the number of times corresponding to the display system designation information.
Patent NZ-554490-A (NZ)
Title: A mortice lock
Inventor: GOETZ MARTIN
IPC: E05B63/08
Filed: 2005-10-11
Abstract: A mortice, or mortise, lock housing (12) supports two split hub handle actuators (15), one to each side of the housing, that are independently rotatable to engage with a locking bolt (13) to withdraw the locking bolt into the housing from a front of the housing. A locking bar (20) can slide within the housing between an unlocked condition and a locked condition, and can selectively actuate one or both or neither of the handle actuators. Two detents (22a, 22b) carried by the locking bar, are each independently moveable relative to the locking bar between an unlocked position and a locked position, each detent in the locked position stopping actuation of a corresponding handle actuator. A biased member (39) associated with each detent and accessed from a rear of the housing enables the detent to move linearly between the unlocked and locked position. The biased members may be press buttons biased by a spring.
Patent NZ-563821-A (NZ)
Title: Process for the production of a low molecular weight heparin
Inventor: FLENGSRUD RAGNAR
IPC: A61K31/726
Filed: 2006-05-09
Abstract: A process for the production of a very low molecular weight heparin (VLMWH; <3000Da) composition in dry form, having a VLMWH content, relative to total heparin content, of at least 10% wt, said process comprising chromatographically or chemically or by filtration reducing the relative proportion of heparin having a molecular weight above 8000Da in a heparin composition extracted from a non-mammalian, vascularised marine animal and drying the resulting composition. A non-mammalian marine animal very low molecular weight heparin (VLMWH) composition in dry form, having a VLMWH content, relative to total heparin content, of at least 20% wt., optionally containing a physiologically acceptable carrier or excipient and/or a drug substance, and optionally coated onto a substrate.
Patent NZ-565018-A (NZ)
Title: A fluoropolymer based dust suppression disposal agent composition
Inventor: KONABE KAZUO
Filed: 2005-06-29
Abstract: Disclosed is a composition for dust-preventive treatment comprising aqueous dispersion of fluorine-containing polymer showing a low potential for environmental concerns and a dust prevention effect as high as that of known composition for dust-preventive treatment, wherein the composition comprises aqueous dispersion of fluorine-containing polymer containing 50 ppm or less of a fluorine-containing emulsifier. This composition for dust-preventive treatment is obtained by removing the fluorine-containing emulsifier from polymer dispersion prepared by polymerizing tetrafluoroethylene using the fluorine-containing emulsifier.
Patent NZ-565069-A (NZ)
Title: Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
Inventor: TAYLOR KIMBERLY LOUISE
IPC: C07K16/12
Filed: 2006-06-13
Abstract: Provided is a composition comprising a LukS-PV subunit of S. aureus and one or more additional bacterial antigens selected from the group consisting of S. aureus Type 5, S. aureus Type 8, S. aureus 336, and a-toxin and a pharmaceutically acceptable carrier. The composition can be used in vaccines for Staphylococcus aureus infections.
Patent NZ-565620-A (NZ)
Title: An adjustable pie cutter with a plurality of blades with tabs, and a core
Inventor: PETERSON SARAH S
Filed: 2008-01-31
Abstract: A food slicing device is disclosed. The device comprises a plurality of blades 20, which have a top edge, and an opposing bottom edge 24. Each of the plurality of blades also has a first and second end. The first end of each of the blades is positioned adjacent to one another at a central axis. The second end of each of the blades extends radially outward from the central axis. A core 31 is secured to each of the plurality of blades relatively closer to the top edge than the bottom edge which holds the blades in position. The core further comprises a first plurality of slots 37, and each of the plurality of blades further comprises a tab 28. Each of the first plurality of slots is sized and configured to receive a corresponding one of the plurality of tabs.
Patent NZ-565668-A (NZ)
Title: Piperidinyl-substituted isoquinolone derivatives as RHO-kinase inhibitors
Inventor: PLETTENBURG OLIVER
IPC: A61K31/4725
Filed: 2006-07-20
Abstract: Disclosed is an (isoquinolin-6-yl-oxy)- piperidine compound of formula (I) or (I') wherein the substituents are defined in the specification or their pharmaceutically acceptable salts and/or stereoisomeric forms. Also disclosed is the use of said compound for producing a medicament for treatment or prevention of diseases associated with Rho-kinase e.g. hypertension.
Patent NZ-569143-A (NZ)
Title: Immunoglobulins directed against NOGO
Inventor: CLEGG STEPHANIE JANE
IPC: A61K39/395
Filed: 2006-12-14
Abstract: Disclosed is an isolated antibody capable of binding to human NOGO-A and comprising specific heavy and light chain variable regions as disclosed in the specification. The antibody is used in the preparation of a medicament for treatment of stroke, other neurological diseases/disorders or for the treatment of a patient suffering from a mechanical trauma to the central or peripheral nervous system.
Patent NZ-573148-A (NZ)
Title: System for acquiring and verifying vehicle and driver data using radio interrogator device
Inventor: ROSEN ILAN
IPC: G08G1/017
Filed: 2007-04-17
Abstract: Disclosed is a system for monitoring vehicles and drivers. The system includes an electronic documentation retriever and transmitter. This electronic documentation retriever and transmitter is for receiving and reading data from driver regulatory documents, reading vehicle data from at least one storage medium and transmitting signals related to the driver regulatory documents and vehicle data. A law enforcement device is also included which is adapted to interrogate the electronic documentation retriever and transmitter and receive the transmitted signals. The regulatory documents comprise driver data.
Patent NZ-578180-A (NZ)
Title: Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
Inventor: SINHA UMA
IPC: A61K31/40
Filed: 2007-11-15
Abstract: Disclosed is the use of a coagulation inhibiting amount of a N-(S-chloro-pyridin-2-yl)-2-(4-imido-benzoyl-amino)-S-methoxybenzamide of Formula II or pharmaceutically acceptable salt thereof, in the manufacture of a medicament form inhibiting coagulation in a human patient in need thereof, wherein the coagulation inhibiting amount of the compound is an aggregate daily dose of between about 0.1 and about 2.0 mg/kg.
Patent NZ-581748-A (NZ)
Title: Treatment of allergic disease with immunomodulator compounds
Inventor: KOLOBOV ALEXANDR A
IPC: A61K38/00
Filed: 2008-05-13
Abstract: Disclosed is the use of an immunomodulator compound of Formula A, or a pharmaceutically acceptable salt thereof, in the preparation of a dosage form for treating, preventing, inhibiting or reducing allergic disease or its effects in a subject, wherein, n is 2, R is hydrogen, acyl, or alkyl, and X is L-tryptophan or D-tryptophan. Allergic disease are for example atopic bronchial asthma.
Patent NZ-586255-A (NZ)
Title: A caseless projectile for firing from a small arms weapon
Inventor: HARRISON LESLIE MERVYN
IPC: F42B30/02
Filed: 2005-03-31
Abstract: Disclosed is a projectile (10) comprising a cylindrical body (12) with a first, leading, end (14) and a second trailing axially opposed end (16). An internal cavity (18) is formed between the ends (14 and 16) and holds a volume of propellant material (22). The first end (14) is closed by a nose (20) that is fixed to the body (12). The end (14) is sealed with a base seal (26) that seats a primer (24) for igniting the propellant (22). The primer (24) is located inboard of the second end (16) and the base seal (26) to reduce the likelihood of accidental activation. Seals (30) are formed about the body (12) for maintaining gas pressure of deflagrating propellant. The seals (30) may be formed integrally with the body (12) or separately from the body (12) and seated in respective grooves formed circumferentially about the body (12).
Patent NZ-586914-A (NZ)
Title: Permanent set elastomeric film and laminate for improving the fit and comfort of garments
Inventor: MUSLET IYAD
IPC: B32B25/14
Filed: 2009-01-23
Abstract: Disclosed is an elastomeric film comprising a layer comprising:(i) at least one olefin-based elastomeric polymer, said at least one olefin-based elastomeric polymer being selected from the group consisting of olefin block copolymer, olefin random copolymer, ethylene copolymer, propylene copolymer, and mixtures thereof, and (ii) at least one draw down polymer present in a combined amount from wt% to 25 wt% of said layer to produce the elastomeric film with a basis weight of no more than 25 gsm, said at least one draw down polymer being selected from the group consisting of linear low density polyethylene, high density polyethylene, homopolymer polypropylene, and mixtures thereof, wherein said elastomeric film has a basis weight of no more than 25 gsm and said elastomeric film has a permanent set, as measured per ASTM D882-97, of no more than 14% after recovery from being initially stretched to 100% of its original size.
Patent NZ-587308-A (NZ)
Title: Use of tetramic acid derivatives for controlling animal pests after treatment of the trunk, the branches, the inflorescences or the buds
Inventor: FISCHER REINER
IPC: A01N43/38
Filed: 2009-02-06
Abstract: Disclosed is the use of tetramic acid derivatives represented by general formula (I) or (II) for controlling thrips after bud treatment.
Patent NZ-596552-A (NZ)
Title: Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
Inventor: AAY NAING
IPC: C07D487/04
Filed: 2010-05-25
Abstract: 596552 Disclosed herein are compounds of formula I, wherein the variables are defined in the specification; a method of preparation thereof; and the use thereof for treating a disease wherein the disease is a cancer, such as breast cancer, mantle cell lymphoma, renal cell carcinoma, acute myelogenous leukemia, chronic myelogenous leukemia, NPM/ALK-transformed anaplastic large cell lymphoma, diffuse large B cell lymphoma, rhabdomyosarcoma, ovarian cancer, endometrial cancer, cervical cancer, non small cell lung carcinoma, small cell lung carcinoma, adenocarcinoma, colon cancer, rectal cancer, gastric carcinoma, hepatocellular carcinoma, melanoma, pancreatic cancer, prostate carcinoma, thyroid carcinoma, anaplastic large cell lymphoma, hemangioma, glioblastoma, or head and neck cancer. Exemplary embodiments of a compound of formula I include the following: 4-(azocan-1-ylcarbonyl)-7-(2-methyl-1H-benzimidazol-6-yl)-2,3,4,5-tetrahydro-1,4-benzoxazepine; (2-methyl-1H-benzimidazol-6-yl)-4-{ [4-(4-nitrophenyl)piperazin-lyl]carbonyl} -2,3,4,5-tetrahydro-1,4-benzoxazepine; 1-[4-(4-{ [7-(2-methyl-1H-benzimidazol-6-yl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl]carbonyl} piperazin-1-yl)phenyl]ethanone; 4-{ [4-(furan-2-ylcarbonyl)piperazin-1-yl]carbonyl} -7-(2-methyl-1H-benzimidazol-6-yl)-2,3,4,5-tetrahydro-1,4-benzoxazepine; and N-methyl-7-(2-methyl-1H-benzimidazol-6-yl)-N-[(3-methylphenyl)methyl]-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxamide.
Patent NZ-601178-A (NZ)
Title: Tracking and monitoring camera device and remote monitoring system using same
Inventor: KIM BAE HOON
IPC: G03B30/00
Filed: 2010-10-11
Abstract: Disclosed is a monitoring camera apparatus having a fixed wide-angle camera unit (12) and a directable camera unit (within dome 50) within one body. The camera apparatus includes a main frame (10) having a supporting protrusion (18) projecting outwards and having a front surface directed downwards and outwards. The camera apparatus also includes the first camera unit (12), installed in the main frame (10) and including a wide-angle lens (14) attached on the front surface of the supporting protrusion (18) in such a manner that an optical axis of the first camera unit (12) is directed downwards and outwards. The first camera unit (12) has a first image sensor for converting light entering through the wide-angle lens (14) into an electrical signal, for photographing a wide angle image of neighbouring areas including a position directly below the camera apparatus. The second camera unit has a second image sensor and is installed so as to pan and tilt with respect to the main frame (10). A control unit is also provided for detecting a moving object from the wide angle image acquired by the first camera unit (12) and controlling rotation of the second camera unit so that the second camera unit photographs the moving object.
Patent NZ-601667-A (NZ)
Title: Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
Inventor: YANG MEIDONG
IPC: C07D307/94
Filed: 2011-02-25
Abstract: This disclosure is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise the (S)-enantiomer of 1’-{ [5-(trifluoromethyl)furan-2-yl]methyl} spiro[furo[2,3-f][1,3]benzodioxole-7,3’-indol]-2’(1’H)-one, or a pharmaceutically acceptable salt thereof and two or more excipients such as solvents, one or more penetration enhancing agents, one or more stiffening agents, or one or more ointment bases. These pharmaceutical compositions are useful for the treatment and/or prevention of pain such as neuropathic pain, inflammatory pain, visceral pain, post-herpetic neuralgia, cancer pain, chemotherapy pain, trauma pain, surgical pain, post-operative pain, pruritis, osteoarthritis pain, trigeminal neuralgia, familial erythromelalgia, primary erythromelalgia, familial rectal pain, childbirth pain, labor pain, neurogenic bladder, ulcerative colitis pain, chronic pain, persistent pain, peripherally mediated pain, centrally mediated pain, chronic headache pain, migraine headache pain, sinus headache pain, tension headache pain, phantom limb pain, or peripheral nerve injury pain, and combinations thereof.
Patent NZ-602474-A (NZ)
Title: Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
Inventor: GRAYBURN PAUL A
IPC: C12N5/10
Filed: 2009-11-13
Abstract: 602474 Provided is a composition for ultrasound-targeted microbubble destruction in the pancreas comprising: a pre-assembled liposome-nucleic acid microbubble complex comprising a nucleic acid; the nucleic acid characterized in that it comprises two or more insulin responsive regulatory genes operatively linked to one or more insulin promoters, characterized in that it comprises a genomic fragment comprising a 5' untranslated region of exon1, intron1, and exon2 of the insulin gene, wherein the two or more insulin responsive regulatory genes comprise one or more cell cycle proteins selected from a member of the cyclin family and one or more members the cyclin dependent kinase family, wherein disruption of the microbubble in the pancreas at a target site delivers the nucleic acid into pancreas cells at the location of the ultrasound disruption, wherein cells that incorporate the nucleic acid express insulin in response to high blood glucose levels. The composition can be used to treat diabetic patients to restore insulin responsiveness.
Patent NZ-606440-A (NZ)
Title: Tackifiers for composite articles
Inventor: BOUGUETTAYA MOHAMED
IPC: B32B5/16
Filed: 2011-08-03
Abstract: Disclosed is a composite article comprises a plurality of lignocellulosic pieces and an adhesive system disposed on the plurality of lignocellulosic pieces for bonding the plurality of lignocellulosic pieces. The adhesive system comprises a binder component consisting of an isocyanate component selected from the group of diphenylmethane diisocyanates, polymeric diphenylmethane diisocyanates, and combinations thereof, and a tackifier component comprising a cationic polymer. The composite article may be various engineered lignocellulosic composites, such as particleboard.
Patent NZ-606480-A (NZ)
Title: Albumin binding peptide-mediated disease targeting
Inventor: TRIEU VUONG
IPC: A61K39/00
Filed: 2009-12-07
Abstract: Disclosed is a composition comprising a conjugate molecule which comprises a peptide ligand domain conjugated to an active agent, wherein the peptide ligand domain comprises a peptide of less than 50 amino acids and comprises SEQ ID NO: 2, as defined in the specification. Also disclosed is the use of said conjugate molecule in the manufacture of a medicament for the treatment of cancer.